Endava Ltd. DAVA 深 沪
等待开盘 05-19 09:30:00 美东时间
4.00
+0.160
+4.17%
华盛通- 最 高4.085
- 今 开3.83
- 成交量 44.07万股
- 最 低 3.8233
- 昨 收 3.84
- 总市值 2.11亿
- 52周最高 17.36
- 市盈率 静 8.58
- 换手率 0.83%
- 52周最低 3.61
- 委 比 72.91%
- 总股本 5284.27万
- 历史最高 172.41
- 量 比 1.05
- 振 幅 6.82%
- 历史最低 3.61
- 每 手 1
- 风险率 3.97%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多美股大行评级 | 目标价31美元，潜在涨幅64%！多家大行首予PayPay"买入"评级； 大摩上调希捷科技目标价从468美元升至582美元
今日重点评级关注：Canaccord Genuity：维持Taysha Gene Therapies"买入"评级，目标价从14美元升至17美元；Guggenheim：维持天演药业"买入"评级，目标价从9美元升至10美元
04-07 11:53
TD Cowen Maintains Buy on Endava, Lowers Price Target to $6
TD Cowen analyst Bryan Bergin maintains Endava (NYSE:DAVA) with a Buy and lowers the price target from $6.5 to $6.
04-06 22:31
美股大行评级 | 潜在涨幅214.14%！HC Wainwright & Co.：Ardelyx获机构升目标价至18美元，维持"买入"评级
今日重点评级关注：HC Wainwright & Co.：维持Ardelyx"买入"评级，目标价从10美元升至18美元；Truist Securities：维持Praxis Precision Medicine"买入"评级，目标价从500美元升至700美元
02-23 08:56
JP Morgan Maintains Neutral on Endava, Lowers Price Target to $9
JP Morgan analyst Puneet Jain maintains Endava (NYSE:DAVA) with a Neutral and lowers the price target from $10 to $9.
02-21 03:45
美股大行评级 | 潜在涨幅108.69%！Stephens & Co.维持圣玛丽石油勘测"超配"评级，上调目标价至49美元
今日重点评级关注：Stephens & Co.：维持圣玛丽石油勘测"超配"评级，目标价从48美元升至49美元；花旗：维持IDEAYA Biosciences"买入"评级，目标价从64美元升至65美元
02-20 15:57
Endava Narrows FY2026 Adj EPS Guidance from USD$1.08-$1.19 to $1.10-$1.18 vs $0.40 Est; Raises FY2026 Sales Guidance from $992.267M-$1.014B to $1.008B-$1.028B vs $968.410M Est
Endava (NYSE:DAVA) narrows FY2026 Adj EPS guidance from $1.08-$1.19 to $1.10-$1.18 vs $0.40 analyst estimate. Raises FY2026 sales outlook from $992.267 million-$1.014 billion to $1.008 billion-$1.028 billion vs $968.410
02-19 20:29
Endava Q2 Earnings Report: What Investors Need to Know
Endava (NYSE:DAVA) released its Q2 earnings on Thursday, February 19, 2026 at 0...
02-19 20:28
Endava Q2 Adj. EPS $0.21 Beats $0.05 Estimate, Sales $244.868M Beat $236.350M Estimate
Endava (NYSE:DAVA) reported quarterly earnings of $0.21 per share which beat the analyst consensus estimate of $0.05 by 320 percent. This is a 45.45 percent decrease over earnings of $0.39 per share from the same period
02-19 20:26
Earnings Scheduled For February 19, 2026
Companies Reporting Before The Bell • Deere (NYSE:DE) is expected to report qua...
02-19 19:11
Guggenheim Maintains Buy on Endava, Lowers Price Target to $13
Guggenheim analyst Jonathan Lee maintains Endava (NYSE:DAVA) with a Buy and lowers the price target from $15 to $13.
02-13 21:02
